What is CytomX Therapeutics's price / earnings?

CytomX Therapeutics (CTMX) reported price / earnings of 18.8× in Q3 2025.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

CytomX Therapeutics CTMX Price / earnings

Price / earnings at other companies

PfizerPFE

14.7×—

AmgenAMGN

24.3×-3.9×

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

CapEx--100%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$707.53M+87.9%

Enterprise value$681.56M+104%

P/S19.9×+17.2×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Calculated from CytomX Therapeutics’s reported figures.

market cap/net income=18.8×

Based on the most recent quarter.

The official record: CytomX Therapeutics’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's price / earnings?: CytomX Therapeutics (CTMX) reported price / earnings of 18.8× in Q3 2025.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.